Doctor profile · Federal record
Dr. Todd Freudenberger, M.D.
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Critical Care Medicine (Internal Medicine) Physician · Bellevue, WA
- NPI 1932122876
- Accepts Medicare
- MIPS 79.2 / 100 · 2023
- 32 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1135 116Th Ave Ne, Suite 600
Bellevue, WA 980044623
(425) 454-2671
fax (425) 990-5260 - Mailing address
-
1135 116Th Ave Ne Ste 600
Bellevue, WA 980044623
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- March 9, 2012
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Washington #MD00036246
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932122876. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
731
Distinct HCPCS
10
Medicare allowed
$80,832
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 294 | 169 | $137 | |
87635 |
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 90 | 86 | $50 | |
94729 |
Test to examine how well the lungs exchange gases | 77 | 75 | $68 | |
99291 |
Critical care, first 30-74 minutes | 65 | 37 | $227 | |
94010 |
Test to measure expiratory airflow and volume | 54 | 53 | $32 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 47 | 45 | $46 | |
94726 |
Test to determine lung volumes using sensors | 33 | 32 | $65 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 24 | 18 | $128 | |
99292 |
Critical care, each additional 30 minutes | 20 | 20 | $114 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 16 | 16 | $243 |
In context: peer comparison
Among 5 peers in Bellevue Pulmonary Disease Physician, average services per provider: 67. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$1,461
Transactions
12
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medical Device Business Services, INC. | 6 | $1,230.16 | |
| Ethicon INC. | 4 | $185.53 | |
| Abiomed | 1 | $27.51 | |
| Erbe USA INC | 1 | $18.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,161
Patients
287
Total drug cost
$1,268,053
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 146 | 59 | $1,308 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 145 | 32 | $121,353 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 122 | 32 | $84,611 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 105 | 55 | $4,140 |
| Montelukast Sodium | Generic | 89 | 17 | $1,062 |
| Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) | Brand | 71 | 12 | $20,610 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 65 | 19 | $50,644 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 63 | 17 | $58,614 |
| Azithromycin | Generic | 59 | 20 | $920 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 57 | 0 | $25,956 |
Hospital affiliations
Frequently asked questions
What is Dr. Todd Freudenberger's medical specialty?
Dr. Todd Freudenberger practices Pulmonary Disease Physician in Bellevue, WA.
Where does Dr. Todd Freudenberger practice?
Dr. Todd Freudenberger practices at 1135 116Th Ave Ne, Bellevue, WA 980044623. Office phone: 4254542671.
What is Dr. Todd Freudenberger's NPI?
Dr. Todd Freudenberger's National Provider Identifier (NPI) is 1932122876, issued by NPPES.
Does Dr. Todd Freudenberger accept Medicare assignment?
Yes. Dr. Todd Freudenberger accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Todd Freudenberger commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS 87635); Test to examine how well the lungs exchange gases (HCPCS 94729). Source: CMS Medicare Physician & Other Practitioners file.